Matthew Hufford - Beirne B. Carter Center for Immunology Research, University of Virginia

基本信息

Career Trajectory

Bio

I received my PhD in Microbiology and Immunology at the University of Virginia. I investigated the regulation of adaptive immune system mediated anti-viral activity in the context of influenza infection. I am currently a Research Fellow at Indiana University School of Medicine. I am investigating the molecular signals underlying CD4+ T cell cell differentiation, particularly during the development of atopic disease and ulcerative colitis.

Research Interests

Papers共 52 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19

Dipak R. Patel, Lisa Macpherson, Martin Bohm,Himanshu Upadhyaya, Carmen Deveau,Ajay Nirula,Paul Klekotka,Mark Williams,Matthew M. Hufford

Infectious Diseases and Therapy（2024）

Cited0Views0WOSBibtex

ERG Functionally Overlaps with Other Ets Proteins in Promoting TH9 Cell Expression ofIl9during Allergic Lung Inflammation

Rakshin Kharwadkar,Benjamin J. Ulrich,Michelle Chu,Byunghee Koh,Matthew M. Hufford,Yongyao Fu,Graeme M. Birdsey,Bo T. Porse,Anna M. Randi,Mark H. Kaplan

The Journal of Immunologyno. 5 (2023): 537-546

Cited1Views0Bibtex

ERG Functionally Overlaps with Other Ets Proteins in Promoting T_H9 Cell Expression of Il9 during Allergic Lung Inflammation

Rakshin Kharwadkar,Benjamin J. Ulrich,Michelle Chu,Byunghee Koh,Matthew M. Hufford,Yongyao Fu,Graeme M. Birdsey,Bo T. Porse,Anna M. Randi,Mark H. Kaplan

Journal of immunology (Baltimore, Md. : 1950)no. 5 (2023): 536-546

Cited0Views0WOSBibtex

Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: an Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial

Himanshu P. Upadhyaya,Jenny Y. Chien,Amanda J. Long, Martin S. Bohm,Nicole L. Kallewaard,Lisa F. Macpherson,Dipak R. Patel,Matthew M. Hufford,Constance J. Krull,Jocelyn Y. Ang,Peter Chen,William J. Muller, Jeffrey A. Potts, Timothy Quinn,Mark Williams

Infectious diseases and therapyno. 7 (2023): 1861-1873

Cited1Views0WOSBibtex

Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19

M. Dougan, M. Azizad,P. Chen, B. Feldman,M. Frieman,A. Igbinadolor,P. N. Kumar, J. Morris, J. Potts,L. Baracco, L. Macpherson, N. Kallewaard, D. Patel,M. M. Hufford, L. Wietecha,E. Chigutsa, S. L. Demmon,B. E. Jones,A. Nirula, D. Skovronsky,M. Williams,R. L. Gottlieb

medRxiv (2022)

Cited37Views0Bibtex

Bamlanivimab and Etesevimab Improve Symptoms and Associated Outcomes in Ambulatory Patients at Increased Risk for Severe Coronavirus Disease 2019: Results from the Placebo-Controlled Double-Blind Phase 3 BLAZE-1 Trial

Peter Chen,Gerhard Behre,Corey Hebert,Princy Kumar,Lisa Farmer Macpherson,Peita Louise Graham-Clarke,Inmaculada de la Torre,Russell M. Nichols,Matthew M. Hufford,Dipak R. Patel,April N. Naegeli

Open forum infectious diseases（2022）

Cited2Views0WOSBibtex

Neutralizing monoclonal antibodies for treatment of COVID-19

Peter C. Taylor,Andrew C. Adams,Matthew M. Hufford,Inmaculada de la Torre,Kevin Winthrop,Robert L. Gottlieb

NATURE REVIEWS IMMUNOLOGY（2021）

Cited527Views0WOSNATUREBibtex

527

Novel Methodology Comparing Two Assay Formats for the Assessment of Immunogenicity from Clinical Trial Samples

Daniel A. Peterson,Thomas G. Pottanat,Heather Denning,Nicoletta Bivi,John H. Sloan,Huy T. Nguyen,Matthew M. Hufford,Robert J. Konrad,Michael E. Hodsdon

Bioanalysis（2021）

Cited0Views0WOSBibtex

Ixekizumab, with or Without Concomitant Methotrexate, Improves Signs and Symptoms of PsA: Week 52 Results from Spirit-P1 and Spirit-P2 Studies

Combe Bernard,Tsai Tsen-Fang,Huffstutter J. Eugene,Sprabery Aubrey Trevelin,Lin Chen-Yen,Park So Young,Kronbergs Andris,Hufford Matthew M.,Nash Peter

Arthritis Research & Therapy（2021）

Cited14Views0Bibtex

Neutralizing Monoclonal Antibodies for Treatment of COVID-19

Peter C. Taylor,Andrew C. Adams,Matthew M. Hufford, Inmaculada de la Torre,Kevin Winthrop,Robert L. Gottlieb

Nature Reviews Immunology（2021）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn